150 related articles for article (PubMed ID: 38275631)
1. Development of Acridone Derivatives: Targeting
Liang JW; Gao ZC; Yang LL; Zhang W; Chen MZ; Meng FH
Antioxidants (Basel); 2023 Dec; 13(1):. PubMed ID: 38275631
[TBL] [Abstract][Full Text] [Related]
2. New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription.
Hu MH; Wu TY; Huang Q; Jin G
Nucleic Acids Res; 2019 Nov; 47(20):10529-10542. PubMed ID: 31584090
[TBL] [Abstract][Full Text] [Related]
3. Non-fused imidazole-biphenyl analogs repress triple-negative breast cancer growth by mainly stabilizing the c-MYC G-quadruplex via a multi-site binding mode.
Wang XD; Wang JX; Yu BY; Zhang SQ; Hu MH
Bioorg Med Chem; 2023 Jun; 88-89():117336. PubMed ID: 37209638
[TBL] [Abstract][Full Text] [Related]
4. New Dibenzoquinoxalines Inhibit Triple-Negative Breast Cancer Growth by Dual Targeting of Topoisomerase 1 and the
Hu MH; Lin JH
J Med Chem; 2021 May; 64(10):6720-6729. PubMed ID: 33961424
[TBL] [Abstract][Full Text] [Related]
5. Syntheses and evaluation of acridone-naphthalimide derivatives for regulating oncogene PDGFR-β expression.
Zhang M; Wei Z; Gong X; Li X; Kang S; Wang J; Liu B; Huang ZS; Li D
Bioorg Med Chem; 2021 Mar; 34():116042. PubMed ID: 33561716
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, and Evaluation of New Sugar-Substituted Imidazole Derivatives as Selective
Li ML; Yuan JM; Yuan H; Wu BH; Huang SL; Li QJ; Ou TM; Wang HG; Tan JH; Li D; Chen SB; Huang ZS
J Med Chem; 2022 Oct; 65(19):12675-12700. PubMed ID: 36121464
[No Abstract] [Full Text] [Related]
7. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
Li M; Li A; Zhou S; Lv H; Yang W
J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a Novel G-Quadruplex and Histone Deacetylase (HDAC) Dual-Targeting Agent for the Treatment of Triple-Negative Breast Cancer.
Jiang XC; Tu FH; Wei LY; Wang BZ; Yuan H; Yuan JM; Rao Y; Huang SL; Li QJ; Ou TM; Wang HG; Tan JH; Chen SB; Huang ZS
J Med Chem; 2022 Sep; 65(18):12346-12366. PubMed ID: 36053318
[TBL] [Abstract][Full Text] [Related]
9. Curcumin arrests G-quadruplex in the nuclear hyper-sensitive III
Roy A; Chatterjee O; Banerjee N; Roychowdhury T; Dhar G; Mukherjee G; Chatterjee S
J Biomol Struct Dyn; 2022; 40(20):10203-10219. PubMed ID: 34192476
[No Abstract] [Full Text] [Related]
10. Synthesis, Molecular Docking, and 2D-QSAR Modeling of Quinoxaline Derivatives as Potent Anticancer Agents against Triple-negative Breast Cancer.
Kaushal T; Khan S; Fatima K; Luqman S; Khan F; Negi AS
Curr Top Med Chem; 2022; 22(10):855-867. PubMed ID: 35331094
[TBL] [Abstract][Full Text] [Related]
11. Development and Characterization of Benzoselenazole Derivatives as Potent and Selective
Wu TY; Chen XC; Tang GX; Shao W; Li ZC; Chen SB; Huang ZS; Tan JH
J Med Chem; 2023 Apr; 66(8):5484-5499. PubMed ID: 37036951
[TBL] [Abstract][Full Text] [Related]
12. Anti-cancer activity of benzoxazinone derivatives via targeting c-Myc G-quadruplex structure.
Jiang S; Awadasseid A; Narva S; Cao S; Tanaka Y; Wu Y; Fu W; Zhao X; Wei C; Zhang W
Life Sci; 2020 Oct; 258():118252. PubMed ID: 32791149
[TBL] [Abstract][Full Text] [Related]
13. Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression.
Felsenstein KM; Saunders LB; Simmons JK; Leon E; Calabrese DR; Zhang S; Michalowski A; Gareiss P; Mock BA; Schneekloth JS
ACS Chem Biol; 2016 Jan; 11(1):139-48. PubMed ID: 26462961
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive
Henry KE; Dilling TR; Abdel-Atti D; Edwards KJ; Evans MJ; Lewis JS
J Nucl Med; 2018 Jan; 59(1):51-57. PubMed ID: 28848040
[TBL] [Abstract][Full Text] [Related]
15. Structure-based design of flavone derivatives as c-myc oncogene down-regulators.
Yang H; Zhong HJ; Leung KH; Chan DS; Ma VP; Fu WC; Nanjunda R; Wilson WD; Ma DL; Leung CH
Eur J Pharm Sci; 2013 Jan; 48(1-2):130-41. PubMed ID: 23127826
[TBL] [Abstract][Full Text] [Related]
16. Selective stabilization of multiple promoter G-quadruplex DNA by using 2-phenyl-1H-imidazole-based tanshinone IIA derivatives and their potential suppressing function in the metastatic breast cancer.
Zeng L; Wu Q; Wang T; Li LP; Zhao X; Chen K; Qian J; Yuan L; Xu H; Mei WJ
Bioorg Chem; 2021 Jan; 106():104433. PubMed ID: 33213893
[TBL] [Abstract][Full Text] [Related]
17. Diclofenac impairs the proliferation and glucose metabolism of triple-negative breast cancer cells by targeting the c-Myc pathway.
Yang L; Li J; Li Y; Zhou Y; Wang Z; Zhang D; Liu J; Zhang X
Exp Ther Med; 2021 Jun; 21(6):584. PubMed ID: 33850556
[TBL] [Abstract][Full Text] [Related]
18. Novel Chiral Ru(II) Complexes as Potential c-myc G-quadruplex DNA Stabilizers Inducing DNA Damage to Suppress Triple-Negative Breast Cancer Progression.
Yuan C; Wang Z; Wang Z; Liu W; Li G; Meng J; Wu R; Wu Q; Wang J; Mei W
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613647
[TBL] [Abstract][Full Text] [Related]
19. Syntheses and Evaluation of New Bisacridine Derivatives for Dual Binding of G-Quadruplex and i-Motif in Regulating Oncogene
Kuang G; Zhang M; Kang S; Hu D; Li X; Wei Z; Gong X; An LK; Huang ZS; Shu B; Li D
J Med Chem; 2020 Sep; 63(17):9136-9153. PubMed ID: 32787078
[TBL] [Abstract][Full Text] [Related]
20. Human MYC G-quadruplex: From discovery to a cancer therapeutic target.
Wang W; Hu S; Gu Y; Yan Y; Stovall DB; Li D; Sui G
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188410. PubMed ID: 32827579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
